Cite
[Curative efficiency of rituximab combined with autologous cytokine induced killer cells on aged patient with orbital diffuse large B cell lymphoma].
MLA
Li, Su-Xia, et al. “[Curative Efficiency of Rituximab Combined with Autologous Cytokine Induced Killer Cells on Aged Patient with Orbital Diffuse Large B Cell Lymphoma].” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 20, no. 5, Oct. 2012, pp. 1117–21. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23114130&authtype=sso&custid=ns315887.
APA
Li, S.-X., Zhu, H.-L., Guo, B., Lu, X.-C., Fan, H., Lin, J., Yang, B., Liu, Y., Yang, Y., Ran, H.-H., Zhai, B., Han, W.-D., Wang, Y., & Yao, S.-Q. (2012). [Curative efficiency of rituximab combined with autologous cytokine induced killer cells on aged patient with orbital diffuse large B cell lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 20(5), 1117–1121.
Chicago
Li, Su-Xia, Hong-Li Zhu, Bo Guo, Xue-Chun Lu, Hui Fan, Jie Lin, Bo Yang, et al. 2012. “[Curative Efficiency of Rituximab Combined with Autologous Cytokine Induced Killer Cells on Aged Patient with Orbital Diffuse Large B Cell Lymphoma].” Zhongguo Shi Yan Xue Ye Xue Za Zhi 20 (5): 1117–21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23114130&authtype=sso&custid=ns315887.